Lilly direct-selling Zepbound at $499/mo — compare with 11 other programs

Personalized treatment selector

60 seconds · 7 questions · ranked recommendation

Step 1 of 7

14%

What's your primary goal?

How this works

We use a transparent rule-based scoring system — every recommendation shows the reasons it matched and any caveats. No black-box AI: you can see exactly why Wegovy ranked above Ozempic for your specific profile, or why Saxenda fell to the bottom.

Three ranking modes let you see the trade-offs explicitly: Balanced weighs everything together; Most effective prioritizes trial-evidence weight loss percentage; Most affordable prioritizes lowest out-of-pocket cost based on your insurance status.

Hard contraindications (e.g., personal/family history of medullary thyroid cancer or MEN2) exclude all GLP-1 medications per FDA boxed warning. We surface this as a result with the recommendation to discuss non-GLP-1 alternatives with your prescriber.

Related

We may earn a commission when you click links to partners. Affiliate disclosure.